Cigna, Humana in Talks To Combine, Reports WSJ
Cigna has been looking to sell its Medicare Advantage business, perhaps as a way to fend off antitrust objection to the deal.
Cigna and Humana are negotiations about a deal that would combine two of the largest private U.S. health insurers, the Wall Street Journal is reporting.
“The companies are discussing at stock-and-cash dela that could be finalized by the end of the year,” the newspaper reported in an article posted at 12:05 p.m.
Several media outlets have reported that Cigna has been looking to sell its Medicare Advantage (MA) business, a move that might help fend off antitrust roadblocks to the combination.
According to KFF (formerly known as the Kaiser Family Foundation), Cigna has a relatively small slice of the growing MA market with 600,000 MA enrollees that account for 2% of the Medicare beneficiaries enrolled in MA plans. Humana, with 5.5 million MA enrollees has 18% of the market and is the second largest MA insurer after UnitedHealthcare.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More
